TAA
MRNA icon

TB Alternative Assets’s Moderna MRNA Stock Holding History

TB Alternative Assets’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-8,700
Closed -$609K – 39
2026
Q2 		$609K Buy
+8,700
New +$450K 0.1% 29
2025
Q4 		– Sell
-658,881
Closed -$17M – 57
2025
Q3 		$17M Sell
658,881
-602,072
-48% -$16.8M 2.55% 14
2025
Q2 		$34.8M Buy
1,260,953
+608,580
+93% +$16M 6.44% 8
2025
Q1 		$18.5M Buy
+652,373
New +$23.2M 4.3% 10
2024
Q2 		– Sell
-59,900
Closed -$6.38M – 42
2024
Q1 		$6.38M Buy
+59,900
New +$6.04M 1.6% 19

Other funds holding MRNA

Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures
Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Leonteq Securities AG
Leonteq Securities AG Zurich, Switzerland $2.44B AUM 50.17% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return

TB Alternative Assets's MRNA Position: Q3 2026 in Review

TB Alternative Assets sold out of Moderna (MRNA) in Q3 2026, closing a stake of 8,700 shares — an estimated $609K sold.

TB Alternative Assets first reported a position in MRNA in Q1 2024 and held it in 5 quarters. The position peaked at $34.8M in Q2 2025. 354 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • TB Alternative Assets reported no remaining Moderna position as of Q3 2026 after selling out during the quarter.
  • TB Alternative Assets sold 8,700 Moderna shares in Q3 2026, an estimated $609K.
  • TB Alternative Assets first reported a position in Moderna in Q1 2024 and held it in 5 quarters.
  • TB Alternative Assets's Moderna position peaked at $34.8M in Q2 2025.
  • 354 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on TB Alternative Assets's 13F filing for Q3 2026, filed 16 Oct 2026.